Shared molecular signatures between coronavirus infection and neurodegenerative diseases provide targets for broad-spectrum drug development

HIGHLIGHTS

• who: Li Deng from the College Hunan University have published the Article: Shared molecular signatures between coronavirus infection and neurodegenerative diseases provide targets for broad-spectrum drug development, in the Journal: Scientific Reports Scientific Reports
• what: This study provides a new strategy for the development of drugs against human diseases which have associations with viral infections such as AD and PD. The drugs shown in the study were directly obtained from the DGIdb database.

SUMMARY

The viral infection-related genes (VIGs) for three coronaviruses including SARS-CoV-2, SARS-CoV and . . .

 



If you want to have access to all the content you need to log in!

Thanks :)

Username or Email

Password

Remember me

Lost your password?

If you don't have an account, you can create one here.